Lidds AB Valuation
| LIDDS Stock | SEK 0.12 0.01 7.69% |
Lidds AB seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Lidds AB from analyzing the firm fundamentals such as Return On Equity of -0.89, shares outstanding of 37.38 M, and Operating Margin of (8.37) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Lidds AB's price fluctuation is out of control at this time. Calculation of the real value of Lidds AB is based on 3 months time horizon. Increasing Lidds AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Lidds stock is determined by what a typical buyer is willing to pay for full or partial control of Lidds AB. Since Lidds AB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lidds Stock. However, Lidds AB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.12 | Real 0.11 | Hype 0.12 | Naive 0.095 |
The intrinsic value of Lidds AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lidds AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Lidds AB helps investors to forecast how Lidds stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lidds AB more accurately as focusing exclusively on Lidds AB's fundamentals will not take into account other important factors: Lidds AB Total Value Analysis
Lidds AB is now projected to have takeover price of 86.88 M with market capitalization of 56.44 M, debt of 0, and cash on hands of 34 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Lidds AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
86.88 M | 56.44 M | 0 | 34 M |
Lidds AB Investor Information
About 19.0% of the company outstanding shares are owned by corporate insiders. The book value of Lidds AB was now reported as 0.72. The company recorded a loss per share of 1.1. Lidds AB had not issued any dividends in recent years. The entity had 326:303 split on the 17th of January 2023. Based on the measurements of operating efficiency obtained from Lidds AB's historical financial statements, Lidds AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Lidds AB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Lidds AB has an asset utilization ratio of 6.39 percent. This implies that the Company is making kr0.0639 for each dollar of assets. An increasing asset utilization means that Lidds AB is more efficient with each dollar of assets it utilizes for everyday operations.Lidds AB Ownership Allocation
Lidds AB maintains a total of 37.38 Million outstanding shares. Lidds AB secures 18.67 % of its outstanding shares held by insiders and 3.37 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Lidds AB Profitability Analysis
The company reported the revenue of 3.55 M. Net Loss for the year was (37.27 M) with loss before overhead, payroll, taxes, and interest of (25.78 M).About Lidds AB Valuation
The stock valuation mechanism determines Lidds AB's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Lidds AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lidds AB. We calculate exposure to Lidds AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lidds AB's related companies.LIDDS AB develops and sells pharmaceutical products for cancer and other diseases worldwide. It is developing various drugs, such as NZ-2HOF to treat prostate cancer NZ-DTX for lung cancer and solid tumors NZ-DOX for solid tumors NZ-IO, an antibody-based immunotherapy NZ-STING for immuno-oncology and NZ-BELINA for breast cancer. LIDDS AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange.
8 Steps to conduct Lidds AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Lidds AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Lidds AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Lidds AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Lidds AB's revenue streams: Identify Lidds AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Lidds AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Lidds AB's growth potential: Evaluate Lidds AB's management, business model, and growth potential.
- Determine Lidds AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Lidds AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Lidds Stock Analysis
When running Lidds AB's price analysis, check to measure Lidds AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lidds AB is operating at the current time. Most of Lidds AB's value examination focuses on studying past and present price action to predict the probability of Lidds AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lidds AB's price. Additionally, you may evaluate how the addition of Lidds AB to your portfolios can decrease your overall portfolio volatility.